Latest filing published 27 Sept 2021 for SLM Corp.
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +41.3%Entry US$7.10 · Close at T+365 US$10.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William N. Shiebler: trading record in brief
Filings by William N. Shiebler span 3 companies, the busiest being Oncotelic Therapeutics, Inc., SLM Corp and Calamos Asset Management, Inc. /DE/. The record holds 59 filings, for trades running from 31 July 2006 to 23 September 2021.
No open-market sale appears; the market trades are 22 purchases worth €299k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 29 share grants and 1 option exercise.
A typical purchase (the median) is worth €2,712. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 27 September 2021 came the latest disclosure, a share grant in SLM Corp. The most recent open-market purchase was published on 23 November 2016, 3,637 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William N. Shiebler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 978 shares0Common StockSEC:0001628280-21-019199:0
- 4,918 shares0Common StockSEC:0001628280-21-012009:0
- 13,003 shares0Common StockSEC:0001628280-20-009796:0
- 2,500 shares@ US$4.3250.0% of flowCommon StockSEC:0001628280-20-000780:0
- 960 shares@ US$11.2650.0% of flowCommon StockSEC:0001628280-20-000780:1
- 10,799 shares0Common StockSEC:0000899243-19-017942:0
- 7,672 shares0Common StockSEC:0001127602-18-021851:0
- 7,373 shares0Common StockSEC:0001127602-17-022126:0
- 15,484 shares@ US$8.2585.5% of flowClass A Common StockSEC:0001258131-17-000007:0
- 2,598.29 shares@ US$8.2514.2% of flowClass A Common StockSEC:0001258131-17-000003:0
- 22.22 shares@ US$7.120.1% of flowClass A Common StockSEC:0001221432-16-000171:0Canonical exit: 20 Feb 2017 (T+90)
- 10,000 shares@ US$7.0276.3% of flowCommon StockSEC:0001127602-16-066236:0Canonical exit: 1 Feb 2017 (T+90)
- 21.57 shares@ US$7.190.1% of flowClass A Common StockSEC:0001221432-16-000165:0Canonical exit: 22 Nov 2016 (T+90)
- 10,989 shares0Common StockSEC:0001127602-16-056359:0
- 19.5 shares@ US$7.800.1% of flowClass A Common StockSEC:0001299033-16-000039:0Canonical exit: 23 Aug 2016 (T+90)
- 5,615 shares0Class A Common StockSEC:0001221432-16-000141:0
- 2,849 shares0Common StockSEC:0001127602-15-029860:0
- 4,985 shares0Common StockSEC:0001127602-15-021636:0
- 3,783 shares0Class A Common StockSEC:0001258131-15-000003:0
- 3,631 shares0Common StockSEC:0001127602-14-021776:0
- 1,641.68 shares0Common StockSEC:0001127602-14-016199:0
- 4,058 shares0Class A Common StockSEC:0001221432-14-000029:0
- 4,563 shares0Class A Common StockSEC:0001258131-13-000003:0
- 35,000 shares@ US$1.14Common Stock, $0.01 par value per shareSEC:0001181431-10-000810:0
- 6,892 shares@ US$0.68Common Stock, $0.01 par value per shareSEC:0001181431-09-044444:4
25 of 44 declarations
